A 2023 study published in JAMA used data from roughly 50,000 UK adults aged 60+ who wore activity trackers to minutely record their movement (and lack thereof) throughout the day. They then used AI to interpret the results and tracked people’s medical status over the next seven years. They found a very strong correlation between long hours of sitting and dementia: Those who sat at…
Unhappiness at Work Is Rising: An Employee Wellbeing Roadmap for Wellness Companies By Thierry Malleret, economist So many new surveys indicate that unhappiness at work has never been such a problem. Macro stressors—from the cost-of-living crisis (notably in Europe) to uncertainty about working from home—are taking a toll on employee wellbeing. Some industries have happier employees than others, like non-profits, perhaps thanks to the sense…
A Phase 2 randomized clinical trial published in the prestigious JAMA found that a single dose of psilocybin (accompanied by psychotherapy) resulted in a rapid, robust and sustained reduction in depressive symptoms for people with major depressive disorder. Earlier studies have suggested that psilocybin may be a promising treatment for depression for people for whom antidepressants and therapy haven’t proven effective, but those studies focused…
Global Survey Reveals Profound “Wellbeing Dilemma” Lululemon just released its annual Global Wellbeing Report, based on a survey of 14,000 people across 14 global markets. It sheds light on how people’s wellbeing has—or hasn’t—changed since 2021. Just a few of its many findings: One out of three respondents report their wellbeing is lower than it has ever been. Although more than two-thirds ranked their wellbeing as a…
Travel and Wellness Are Forecast to Dramatically Outperform Global Economy in Next Decade (With No End in Sight for Ultra-Premium Market) By Thierry Malleret, economist The World Travel and Tourism Council recently made bold predictions: global tourism will become a $15.5 trillion industry over the next 10 years, when it will account for 12% of the global economy (a 50% increase from 2019) and employ 430…
Good-quality studies on aromatherapy are rare. One 2023 randomized trial from the University of California, Irvine had “astonishing” findings. One group of study participants aged 60 to 85 used a diffuser every night for six months (two hours of exposure to natural oil infusions of rose, orange, eucalyptus, lemon, peppermint, rosemary, and lavender), while the other received a sham treatment (trace scent amounts). Participants then underwent…
